Atrophic Vaginitis

• FDA approval · 2025-10-15
  FDA Approved: ESTROGENS, CONJUGATED — Original Application (Ingenus Pharmaceuticals, LLC)

  FDA approved the original application for a generic conjugated estrogens product from Ingenus Pharmaceuticals, LLC, marking entry of this ge…

• FDA approval · 2024-02-16
  FDA Approved: ESTRADIOL VAGINAL CREAM — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application from Prasco Laboratories for Estradiol vaginal cream, granting approval for the generic product.

• FDA approval · 2017-11-07
  FDA Approved: CONJUGATED ESTROGENS — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for Conjugated Estrogens (Estrogens, Conjugated) submitted by Prasco Laboratories.

• FDA approval · 2017-11-01
  FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  The FDA approved a supplemental application for Premarin Vaginal (conjugated estrogens) from Wyeth Pharmaceuticals (Pfizer) to update labeli…

• FDA approval · 2009-11-25
  FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)

  FDA approved a supplemental application for Vagifem (estradiol) from Novo Nordisk. It involves changes to the product's labeling under the s…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2008-03-03
  FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  The FDA approved a supplemental application for PREMARIN VAGINAL (conjugated estrogens) submitted by Wyeth Pharmaceuticals (Pfizer). This ac…